Adaptive Biotechnologies
ADPT
ADPT
213 hedge funds and large institutions have $3.46B invested in Adaptive Biotechnologies in 2021 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 76 increasing their positions, 68 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 218 → 213 (-5)
14% less capital invested
Capital invested by funds: $4B → $3.46B (-$542M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Holders
213
Holding in Top 10
2
Calls
$6.41M
Puts
$1.18M
Top Buyers
| 1 | +$51.6M | |
| 2 | +$32.1M | |
| 3 | +$31.8M | |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$31.2M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$23.6M |
Top Sellers
| 1 | -$28.8M | |
| 2 | -$12.3M | |
| 3 | -$12.1M | |
| 4 |
BAMCO Inc
New York
|
-$12M |
| 5 |
DP
DDD Partners
Bellevue,
Washington
|
-$10.8M |